AOD-9604 Dosing Schedule: Titration, Timing, and Missed Doses

AOD-9604 at a glance:

• Drug class: Metabolic / longevity research peptide
• Route: subcutaneous injection in research
• Typical frequency: no established human regimen
• Half-life: typically short systemically

The wrong AOD-9604 dose — too high, too low, or escalated too quickly — is the most common reason people stop the drug. No FDA-approved human dosing.

Standard Dosing Schedule for AOD-9604

No FDA-approved human dosing.

The typical schedule for AOD-9604 is no established human regimen via subcutaneous injection in research. Half-life of typically short systemically explains why this schedule works — the drug stays active long enough to support that interval.

Titration: Why Starting Low Matters

For this class of compound, gradual titration is the standard approach. The starting doses listed above are not therapeutic — they exist to let the body adapt and to reduce gastrointestinal symptoms .

A typical titration plan for AOD-9604 holds each dose step for at least four weeks before moving up. Faster titration is associated with more dropouts due to side effects.

Missed Doses

If a dose of AOD-9604 is missed: for daily schedules, the rule of thumb is to take it as soon as remembered if within a defined window, otherwise skip it and resume the regular schedule. The exact window depends on the half-life (typically short systemically) and the specific product label. Never double up to make up for a missed dose.

Dose Adjustments

Dose adjustments may be needed for the following:

• Significant weight loss or weight gain
• Side-effect intolerance at the current step
• Changes in renal or hepatic function
• Drug interactions (particularly relevant for any concurrent medications)

We cover the side-effect side of dose decisions in AOD-9604 side effects and the cost angle of dose escalation in AOD-9604 cost.

What the Trials Used

Published clinical data on this compound is limited. Most reported dosing comes from observational or non-clinical sources.

That data drives the labeled dosing range, which is what physicians prescribe by.

Special Populations

The dosing guidance above applies to general adult use. Special populations — pregnancy, pediatric, severe renal impairment, hepatic dysfunction, elderly with frailty — require individualized assessment that this page can't substitute for.

For AOD-9604: the standard contraindications for this drug class apply.

Bottom Line

Most AOD-9604 dose questions resolve in a 5-minute conversation with a clinician. Don't carry them around — get them answered.

Frequently Asked Questions

Related Reading

• AOD-9604 101: A Plain-English Guide for 2026
• AOD-9604 Side Effects Decoded: What's Normal vs. What Isn't
• Real AOD-9604 Results: What 6 and 12 Months Actually Look Like
• AOD-9604 Price Decoded: Insurance, Coupons, and Cash-Pay Options
• NAD+ 101: A Plain-English Guide for 2026
• NAD+ Side Effects Decoded: What's Normal vs. What Isn't

Sources

• Lee C et al. The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis. Cell Metabolism 2015;21:443.
• Birk AV et al. The Mitochondrial-Targeted Peptide SS-31 Selectively Improves Mitochondrial Function. JASN 2013;24:1250.

This page is informational only and is not medical advice. We do not provide guidance for self-administration of compounds that are not FDA-approved.